Market
CRISPR Therapeutics AG [CRSP] Revenue clocked in at $371.21 million, up 37.68% YTD: What’s Next?
CRISPR Therapeutics AG [NASDAQ: CRSP] price surged by 4.59 percent to reach at $3.78. The company report on February 21, 2024 at 7:30 AM that CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results. — CASGEVY™ approved in the U.S., European Union,
